Takeda Pharmaceutical Co Ltd 13F Holdings · last filed Q3 2025
Takeda Pharmaceutical Co Ltd reported 8 securities worth $16.37M in its SEC 13F filing for Q3 2025 (period ended 2025-09-30). Top holdings: OVID (59.82%), EQ (15.94%), XLO (7.59%). Among its top 25 positions this quarter: 1 added, 3 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | OVID | Ovid Therapeutics, Inc. | $9.8M | 59.82% | 7.5M | Hold |
| 2 | EQ | Equillium, Inc. | $2.6M | 15.94% | 1.8M | Hold |
| 3 | XLO | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | $1.2M | 7.59% | 1.5M | Hold |
| 4 | STTK | Shattuck Labs, Inc. | $1.2M | 7.53% | 515,619 | Hold |
| 5 | LYEL | Lyell Immunopharma, Inc. | $891,365 | 5.45% | 54,887 | Added |
| 6 | AMWL | American Well Corporation | $478,061 | 2.92% | 77,733 | Hold |
| 7 | RANI | Rani Therapeutics Holdings, Inc. | $101,554 | 0.62% | 203,190 | Hold |
| 8 | LAB | Standard Biotools, Inc. | $21,470 | 0.13% | 16,515 | Hold |
| 9 | HLVX | HilleVax, Inc. | $0 | 0.00% | 0 | Exited |
| 10 | THRD | Third Harmonic Bio, Inc. | $0 | 0.00% | 0 | Exited |
| 11 | TSBX | Turnstone Biologics | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2025-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR